drugset
drugset / Trial / NCT05177029

Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian Participants

NCT05177029 ↗

Phase 1 Terminated 24 enrolled H. Lundbeck A/S
RandomizedSequentialDouble-blindTreatment

Summary

The main goal of this study is to evaluate the effect of Lu AG06466 on the body and what the body does to Lu AG06466 after single and multiple doses to healthy Japanese and Caucasian participants.

Timeline

Start
2021-11-26
Primary completion
2021-12-29
Completion
2021-12-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG06466 Unknown — Oral

Indications

No indication recorded.